arrow
K

Kei Kunimasa

Okayama University
H指数:25
被引数:2,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter randomized phase III trial comparing MET tyrosine kinase inhibitors versus immune checkpoint inhibitors with or without chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer harboring MET exon 14 skipping mutations: JCOG2506 (DECIDE-MET)

多中心随机III期试验比较MET酪氨酸激酶抑制剂与免疫检查点抑制剂联合或不联合化疗作为携带MET外显子14跳跃突变晚期非小细胞肺癌患者的一线治疗:JCOG2506(DECIDE-MET)

2026-08-200
OAAI
Assessing the impact of comprehensive genome profiling in clinical practice: single-center observational study in Japan

评估综合基因组分析在临床实践中的影响: 日本的单中心观察性研究

2024-10-010
PRE
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells

AXL信号介导KRAS G12C-mutant肿瘤细胞对KRAS G12C抑制剂的适应性耐药

2024-04-010
OAAI
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies

接受癌症免疫疗法治疗的晚期NSCLC患者颅内进展的低频率

2023-08-232
OA